Homeapotherapy research desk Find my starting point

Product fact sheet

PlatinumLED BIOMAX 450

PlatinumLED BIOMAX 450 is a 150-LED panel with seven published wavelength bands, 260 W listed consumption and linked LightLab irradiance and spectrum reports.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →
Desk researchedFacts checked 2026-08-10

A larger 150-LED panel with seven manufacturer-published wavelength bands and independent LightLab reports for a tested BIOMAX 450 sample. Those reports verify specific laboratory measurements, not clinical efficacy.

Fit signals

larger-panel specification comparisons, buyers who want access to third-party hardware test reports

Potential constraints

buyers requiring Homeapotherapy hands-on testing, anyone treating a lab hardware report as proof of a health outcome

Key tradeoff: Its documentation surface is richer than many panels, but sample-specific lab measurements should not be generalized beyond their stated test conditions.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

Hardware and independent test record

PlatinumLED currently lists the BIOMAX 450 with seven wavelength bands—480, 630, 660, 810, 830, 850 and 1060 nm—150 LEDs, 260 W listed power consumption, 19 × 12 × 3 inch product dimensions, a 17 lb listed weight and a three-year warranty.

The manufacturer also links two LightLab International documents for the BIOMAX 450. The 17-page grid report, report number LLIA002684-002, identifies the tested unit as a PlatinumLED BIOMAX 450 with 150 LEDs and records 248.8 W during the test. At a 6-inch test plane, that report gives a center-point total irradiance of 90.36 mW/cm², a 79.79 mW/cm² grid average, and a 106.50 mW/cm² maximum across the reported 350–1700 nm range. The report also contains separate red-band and near-infrared-band grids and measurements at additional distances.

A second LightLab summary, LLIA002639-002A, documents spectral radiant-flux testing of a BIOMAX 450 sample under laboratory conditions. Both PDFs are linked below so readers can inspect the test method and scope directly rather than relying on a marketing summary.

Limits of the LightLab reports

These are independent hardware measurements for the tested sample, not clinical-outcome studies. The irradiance and spectral results should not be generalized beyond the stated test conditions or treated as proof of a health benefit.

Hardware comparison points

The factual comparison points are panel dimensions, seven-band spectrum, LED count, electrical consumption, independent irradiance/spectral documentation, controls, warranty/returns, and the exact wording of any regulatory or certification claims. The independent grid average is especially useful because it describes more than a single center-point reading. It still belongs beside the stated test distance, spectrum and sampling geometry rather than being treated as a universal device dose.

Technical specifications

Published specs and what they mean

Physical

Dimensions
19 × 12 × 3 in
Basis: Manufacturer published Manufacturer-published for BIOMAX 450. Source: BIOMAX Red Light Therapy Panels

Optical

Wavelengths
480 / 630 / 660 / 810 / 830 / 850 / 1060 nm
Basis: Manufacturer published Manufacturer-published spectrum. Source: BIOMAX Red Light Therapy Panels
LED architecture
150 LEDs: 72 red / 75 infrared / 3 blue in LightLab sample
Basis: Independent lab Conditions: LightLab report LLIA002639-002A; submitted sample; test date 2025-04-11; laboratory conditions LightLab spectral report description of the submitted BIOMAX 450 sample. Source: BIOMAX 450 LightLab Summary of Test Results LLIA002639-002A (PDF)
LightLab red-band irradiance at 6 in
40.98 mW/cm² average; 41.03 mW/cm² center
Basis: Independent lab Conditions: 600–700 nm band; 6 in test distance; 7 × 7 grid / 49 measurement points; spectral irradiance meters; sample stabilized per IES LM-79-24 criteria 600–700 nm grid measurement for the tested sample; not total-spectrum irradiance. Source: BIOMAX 450 Grid Application Distance Measurement Test Report LLIA002684-002 (PDF)

Electrical

Manufacturer power consumption
260 W
Basis: Manufacturer published Manufacturer-published nominal figure. Source: BIOMAX Red Light Therapy Panels
LightLab measured electrical power
253.8 W
Basis: Independent lab Conditions: 119.9 Vac; 59.99 Hz; submitted sample; LightLab report LLIA002639-002A; test date 2025-04-11 Electrical summary in LightLab spectral report. Source: BIOMAX 450 LightLab Summary of Test Results LLIA002639-002A (PDF)
LightLab measured current
2.127 A
Basis: Independent lab Conditions: 119.9 Vac; 59.99 Hz; submitted sample; LightLab report LLIA002639-002A; test date 2025-04-11 Electrical summary in LightLab spectral report. Source: BIOMAX 450 LightLab Summary of Test Results LLIA002639-002A (PDF)
LightLab measured frequency
59.99 Hz
Basis: Independent lab Conditions: 119.9 Vac; submitted sample; LightLab report LLIA002639-002A; test date 2025-04-11 Electrical summary in LightLab spectral report. Source: BIOMAX 450 LightLab Summary of Test Results LLIA002639-002A (PDF)
LightLab measured power factor
0.995
Basis: Independent lab Conditions: 119.9 Vac; 59.99 Hz; submitted sample; LightLab report LLIA002639-002A; test date 2025-04-11 Electrical summary in LightLab spectral report. Source: BIOMAX 450 LightLab Summary of Test Results LLIA002639-002A (PDF)
LightLab current THD
7.4%
Basis: Independent lab Conditions: 119.9 Vac; 59.99 Hz; submitted sample; LightLab report LLIA002639-002A; test date 2025-04-11 Electrical summary in LightLab spectral report. Source: BIOMAX 450 LightLab Summary of Test Results LLIA002639-002A (PDF)

What the current record does not establish

  • The LightLab reports cover submitted BIOMAX 450 samples under stated laboratory conditions; Homeapotherapy has not replicated those measurements.
  • No beam-angle value is normalized under the current source set.
  • No current primary manufacturer user manual is included in the normalized source trail, so operating and environmental parameters are less complete than for the MitoPRO profile.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

No comparable independent average irradiance is normalized

This device may have a manufacturer-published irradiance claim, but Homeapotherapy does not calculate time-to-fluence from that number unless the current record contains a sufficiently defined independent area-average measurement. This avoids presenting unlike measurement methods as interchangeable.

What this calculation still cannot tell you

  • whether this is an effective dose for any condition;
  • how irradiance changes at a different distance or across curved anatomy;
  • how much energy reaches tissue below the surface;
  • whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
  • whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 480 / 630 / 660 / 810 / 830 / 850 / 1060 nm.

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Do not infer from wavelength overlap

  • that this device is clinically proven for the linked condition;
  • that more wavelengths are better;
  • that the highest published irradiance is the best dose;
  • that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Follow current device instructions and eye-safety guidance. The linked LightLab reports measure a submitted hardware sample under stated conditions; they do not establish clinical efficacy.

  • Independent lab reports establish measurements for the tested sample and stated conditions; they do not establish clinical efficacy.
  • Do not infer that manufacturer regulatory or certification language is broader than the underlying record or standard.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

Source trail

Primary documents and supporting evidence

  1. BIOMAX Red Light Therapy PanelsPlatinumLED Therapy Lights · Manufacturer · retrieved 2026-08-10
  2. BIOMAX 450 Grid Application Distance Measurement Test Report LLIA002684-002LightLab International Allentown, LLC · Independent lab · PDF · retrieved 2026-08-10
  3. BIOMAX 450 LightLab Summary of Test Results LLIA002639-002ALightLab International Allentown, LLC · Independent lab · PDF · retrieved 2026-08-10
  4. Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · Regulatory · retrieved 2026-08-10